PharmaShots | Incisive News in 3 Shots

Subscribe Now

P-III studies

Gan & Lee Completes P-III Studies of GL-GLA for Patients with T1D & T2D

Gan & Lee Completes P-III Studies of GL-GLA for Patients with T1D & T2D

October 15, 2021

Roche Reports Results of Faricimab in Four P-III Studies for Diabetic Macular Edema and Age-Related Macular Degeneration

Roche Reports Results of Faricimab in Four P-III Studies for Diabetic Macular Edema and Age-Related Macular Degeneration

February 12, 2021

$Merck&Co. Reports Results of Gefapixant (MK-7264) in Two P-III Studies for Refractory or Unexplained Chronic Cough$

Merck&Co. Reports Results of Gefapixant (MK-7264) in Two P-III Studies for Refractory or Unexplained Chronic Cough

March 18, 2020

Vertex Reports Results of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Two P-III Studies for Cystic Fibrosis

Vertex Reports Results of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Two P-III Studies for Cystic Fibrosis

November 1, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us